↓ Skip to main content

Dove Medical Press

Biologic monotherapy in the treatment of rheumatoid arthritis

Overview of attention for article published in Biologics: Targets & Therapy, May 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 284)
  • High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
8 X users
googleplus
1 Google+ user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
76 Mendeley
Title
Biologic monotherapy in the treatment of rheumatoid arthritis
Published in
Biologics: Targets & Therapy, May 2015
DOI 10.2147/btt.s53361
Pubmed ID
Authors

Jacqueline Detert, Pascal Klaus

Abstract

Biologics, possibly in combination with a conventional disease-modifying antirheumatic drug (DMARD) - preferably methotrexate (MTX), are used in accordance with the recommendations of the international rheumatological societies. However, in clinical practice, this recommendation is often problematic, as many rheumatologists know from personal experience. The quality of life of the patient is affected mainly by drug-induced intolerances (eg, MTX). Thus, the acceptance of the patient to treatment is often so inadequate that a discontinuation of the drug is necessary. In daily practice, approximately 30% of patients with biological therapy receive no concomitant DMARD according to the register data.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 18%
Researcher 12 16%
Other 11 14%
Student > Doctoral Student 9 12%
Student > Master 7 9%
Other 15 20%
Unknown 8 11%
Readers by discipline Count As %
Medicine and Dentistry 29 38%
Pharmacology, Toxicology and Pharmaceutical Science 16 21%
Agricultural and Biological Sciences 4 5%
Biochemistry, Genetics and Molecular Biology 4 5%
Computer Science 2 3%
Other 9 12%
Unknown 12 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2017.
All research outputs
#1,958,369
of 25,371,288 outputs
Outputs from Biologics: Targets & Therapy
#15
of 284 outputs
Outputs of similar age
#24,454
of 278,911 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 3 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,911 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them